Depending on one’s perspective, the anti-inflammatory colchicine is either an unsung and underprescribed drug for patients with cardiovascular disease, or it’s an agent with limited clinical benefit ...
NEW YORK — New insights into colchicine's disruption of the pathway that contributes to arterial inflammation and new clinical studies of the drug could pave the way toward greater use of the ...
BASEL, Switzerland—Low-dose colchicine doesn’t significantly reduce MACE in patients who have had a nonsevere ischemic stroke or high-risk TIA, according to the results of the CONVINCE trial. Through ...
Colchicine use is associated with a modest reduction in the long-term risk for total joint arthroplasty (TJA) among individuals with gout, according to study findings published in Arthritis & ...
Please provide your email address to receive an email when new articles are posted on . In patients referred for PCI after acute heart attack, colchicine did not improve heart-related outcomes vs.
Please provide your email address to receive an email when new articles are posted on . Patients taking colchicine had a weighted hazard ratio of 0.82 (95% CI, 0.69-0.94) for cardiovascular events.
Dear Dr. Roach: I’m a 78-year-old man with a stent and a blockage in one of the arteries to my heart. I am on a low-fat diet and take ramipril for cholesterol. My levels are very good (total ...
WASHINGTON — Colchicine does not protect against major cardiovascular adverse events after an acute myocardial infarction, according to a multinational placebo-controlled trial of more than 7000 ...
Colchicine is a potent anti‐inflammatory agent widely employed in the treatment of gout and related conditions. However, its narrow therapeutic window renders it a considerable toxicological risk, ...
Patients with gout are commonly prescribed colchicine prophylaxis, despite already taking medications that could potentially interact. Patients with gout are commonly prescribed colchicine prophylaxis ...
NEW YORK (Reuters Health) - Two recent deaths, and possibly a third, from intravenous colchicine therapy at an alternative medicine clinic were the result of a compounding pharmacy error, health ...
Taking low-dose colchicine daily may slow the progression of a common acquired gene mutation found in the blood of older adults that can lead to certain blood cancers and increased risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results